Agriculture Research Articles & Analysis
20 news found
CD Genomics' Whole Exome Sequencing service is meticulously designed to provide researchers with an all-encompassing view of the coding regions of the genome. ...
This cutting-edge offering promises to provide researchers worldwide with an efficient application solution for DNA affinity purification sequencing technology. ...
BOC Sciences offers high-quality products for its esteemed customers in academia, pharmaceuticals, biotech, CDMO, material sciences, and agriculture to support research and production ...
CD Genomics is a leading global life sciences company committed to providing the research community with high-quality long-read sequencing services, from Oxford Nanopore to PacBio SMRT sequencing. ...
In addition, Bayer will pay research funding and tiered royalties up to low double-digit percentage of net sales. ...
Comprising a team of scientist-founders, experienced biopharma veterans, and talented researchers, Mammoth is developing a robust pipeline of novel CRISPR systems capable of providing permanent cures for genetic conditions, and powering next-generation diagnostic tools to enable decentralized disease detection. ...
Fungi also produce some secondary metabolites, such as penicillin, cyclosporine and lovastatin, which have important medicinal, agricultural or cosmetic prosperities. Fungal genome research is a method to obtain the whole fungal genome sequence through genome sequencing and assembly, and to study its structure and function. In-depth research ...
Mammoth aims to develop permanent genetic cures through best-in-class in vivo and ex vivo therapies and to democratize disease detection with on-demand diagnostics. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and Cas?, Mammoth can provide enhanced diagnostics and genome editing for life science research, ...
Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. By leveraging its internal research and development and exclusive licensing to patents related to Cas12, Cas13, Cas14 and CasΦ, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science ...
Mammoth aims to develop permanent genetic cures through best-in-class in vivo and ex vivo therapies and to democratize disease detection with on-demand diagnostics. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and Cas?, Mammoth can provide enhanced diagnostics and genome editing for life science research, ...
“The combination of Mammoth’s unique technology with Vertex’s unmatched experience in serious disease research and development will only accelerate programs with the goal of reaching patients with high unmet medical ...
Mammoth aims to develop permanent genetic cures through best-in-class in vivo and ex vivo therapies and to democratize disease detection with on-demand diagnostics. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and Cas?, Mammoth can provide enhanced diagnostics and genome editing for life science research, ...
Mammoth Biosciences today announced that it has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most promising private companies in the industry. This designation comes after a year of immense momentum at the company as it leverages its innovative CRISPR platform in the fight against the COVID-19 pandemic and beyond. As a leader in the development of ...
Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today its financial results for the first quarter ending March 31, 2019. Ofer Haviv, Evogene’s President and CEO, stated: “In 2019 we have completed the transition, as planned, to our new corporate structure consisting of Evogene, the company, as a ...
Researchers at the University of Western Australia conducted a review of existing literature, and found that the research gaps include a lack of climate change-scenario modelling for diseases caused by plant viruses, and little information on the effects of drought, flooding and heat waves on plant virus diseases. ...
The genome sequence will enable researchers to use targeted genetic techniques and less guesswork to develop new high-yielding and disease- and stress-tolerant varieties of pigeon pea. "Currently the realised yield is only one-third of the potential yield … because of several stresses such as disease or waterlogging," Rajeev Varshney, the lead scientist and coordinator ...
Research4Life is the collective name given to HINARI, AGORA and OARE, the three public-private partnerships that offer health, agriculture and environmental research for free or at very low cost to developing countries. ...
” Research4Life is the collective name given to HINARI, AGORA and OARE, the three public-private partnerships that offer health, agriculture and environmental research for free or at very low cost to developing countries. ...
The first harvest from Australia shows promising results, according to the researchers from the National Agricultural Research Organisation (NARO) in Uganda and Australia"s Queensland University of Technology. ...
The first part of DEWN, which started last month (June), is the establishment of the farmer network by visiting the groups to train them in recognising cassava disease and communicating with researchers at the Lake Zone Agricultural Research and Development Institute (LZARD). Innocent Ndyetabura, a plant researcher at LZARD, ...